Cited by 259Artificial Intelligence in Healthcare and EducationRetinal Imaging and AnalysisOphthalmology and Visual Health Research

Current Challenges and Barriers to Real-World Artificial Intelligence Adoption for the Healthcare System, Provider, and the Patient

Open access
Singh, Rishi P., Hom, Grant L., Abramoff, Michael D., Campbell, J. Peter, Chiang, Michael F., on behalf of the AAO Task Force on Artificial Intelligence·2020·Translational Vision Science & Technology

Abstract

Artificial intelligence (AI), or the use of automated systems that display the ability to correctly interpret, to learn from, and to achieve specific goals by use of external data, is an emerging technology that has myriad implications for changing the way we interact with the world. Although this technology is already being used in many fields such as banking, retail, and education, AI has the potential to transform other fields including healthcare. Within healthcare, ophthalmology is uniquely positioned to benefit from AI not only through clinical decision support technology but also through improved image processing innovations such as real-time segmentation, automated image quality improvements, and assisted or autonomous disease screening tools.1,2 Although there are now Food and Drug Administration–approved technologies within ophthalmology, such as IDx-DR (Coralville, IA, USA) for early diagnosis of diabetic retinopathy and diabetic macular edema, numerous challenges still exist to realize the potentially transformative impact of these technologies in day to day practice. The need for the ophthalmology community to take a thoughtful approach to AI innovation and implementation is accentuated by the high stakes involved. The impact of misleading patients and clinicians on a health condition is much greater than a retail store misinterpreting the next book you may like to buy. As a result, we need to increase discussion about the issues surrounding who, what, when, how, and why we might use AI in practice, including ethical and liability considerations, to determine how best to implement AI for all stakeholders including practitioners, patients, practices/hospitals, and industry. This article aims to highlight the challenges and barriers to real-world AI adoption that impact the technology's utility. We examine these specific challenges that will face health care organizations, providers, and patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1167/tvst.9.2.45

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human trust is an important factor, and further education on AI and transparency information can build this trust for clinicians and patients.

    “Human trust is an important factor, and further education on AI and transparency information can build this trust for clinicians and patients [59–61].”

    From Use of artificial intelligence in critical care: opportunities and obstacles (2024) · cites this paper as [60]

    The ‘Will Patients Embrace This Technology?’ section identifies trust in data security as a factor in patients’ acceptance of AI. The ‘Building an AI Competent Physician Workforce’ section calls for AI education for clinicians, and ‘Considerations for Adopting Existing AI Technology’ discusses more explainable AI. The paper does not say that education or transparency information builds trust for both clinicians and patients. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. [3]Lehne M, Sass J, Essenwanger A, Schepers J, Thun S Why digital medicine depends on interoperability. npj Digit Med. 2019; 2: 1– 5, doi: 10.1038/s41746-019-0158-1. 31453374 PMC6702215 · DOI · Paper page
  2. [4]Holm EA. In defense of the black box. Science. 2019; 364: 26– 27, doi: 10.1126/science.aax0162. 30948538 · DOI
  3. [6]Woo M. An AI boost for clinical trials. Nature. 2019; 573: S100– S102, doi: 10.1038/d41586-019-02871-3 31554996 · DOI
  4. [8]Lieberman H. User interface goals, AI opportunities. AI Mag. 2009; 30: 16– 22, doi: 10.1609/aimag.v30i4.2266. · DOI
  5. [11]Paranjape K, Schinkel M, Nannan Panday R, Car J, Nanayakkara P Introducing artificial intelligence training in medical education. JMIR Med Educ. 2019; 5: e16048, doi: 10.2196/16048. 31793895 PMC6918207 · DOI · Paper page
  6. [12]Zhang B, Dafoe A. U.S. Public opinion on the governance of artificial intelligence. In: AIES 2020—Proceedings of the AAAI/ACM Conference on AI, Ethics, and Society. New York, NY, USA: Association for Computing Machinery, Inc; 2020: 187– 193, doi: 10.1145/3375627.3375827. · DOI
  7. [15]Beauchamp TL, Childress JF. Principles of biomedical ethics. Eighth edition Ed. New York: Oxford University Press; 2019.
  8. [17]Abramoff MD, Lavin PT, Birch M, Shah N, Folk JC Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. Nature Digital Medicine. 2018; 1: 39, doi: 10.1038/s41746-018-0040-6. PMC6550188 31304320 · DOI · Paper page
  9. [18]Char DS, Abramoff MD, Feudtner C Identifying potential ethical concerns in the conceptualization, development, implementation, and evaluation of machine learning healthcare applications. The American Journal of Bioethics. 2020 [in press]. PMC7737650 33103967
  10. [19]Abramoff MD. The autonomous point of care diabetic retinopathy examination. In: Klonoff DC Kerr D Mulvaney SA, eds. Diabetes Digital Health. Amsterdam, Netherlands: Elsevier; 2020.
  11. [20]American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes—2020. Diabetes Care. 2020; 43(Suppl 1): S135– S151. 31862754
  12. [21]Blumenthal D Launching HITECH. N Engl J Med. 2010; 362: 382– 385, doi: 10.1056/NEJMp0912825. 20042745 · DOI

Cited by

Sorted by citations

Authors
Singh, R. P., Hom, G. L., Abramoff, M. D., Campbell, J. P., Chiang, M. F., & on behalf of the AAO Task Force on Artificial Intelligence
Affiliations
  • Cleveland Clinic (US)
  • Case Western Reserve University (US)
  • Retina Service, Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA
  • Oregon Health & Science University (US)
Corresponding author
Singh, Rishi P.
Venue
Translational Vision Science & Technology
Published
2020-08-11
Volume
9
Issue
2
Pages
45
ISSN
2164-2591 (ISSN-L)
OpenAlex
W3048871739
Cited by
259
References
4
Citations by year
2026: 43 · 2025: 65 · 2024: 75 · 2023: 36 · 2022: 25 · 2021: 13 · 2020: 2
FWCI
5.60
Type
journal article
Language
en
Open access
Locations
  • Translational Vision Science & Technology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Eye Institute (R01EY019474, K12EY027720, P30EY010572)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD107493)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
Keywords
artificial intelligence adoption, ophthalmology, clinical decision support, diabetic retinopathy screening, AI implementation barriers, AI ethics, liability, patient trust, automated image analysis, real-world implementation
MeSH terms
Artificial Intelligence, Delivery of Health Care, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review